Table 2.

Odds ratios and 95% confidence intervals for risk of prostate cancer by quartile of adiponectin

Quartile of adiponectin
P
Q1Q2Q3Q4
Cases, % [(n)/total (N)]24/73 (32)26/73 (35)13/74 (17)12/73 (16)
Adiponectin
    Median (range), ng/mL3.4 (0.9–5.3)6.8 (5.3–8.7)10.7 (8.7–13.7)18.7 (13.7–43.2)
Cases vs control subjects
    Age adjusted1.00.74 (0.28–1.94)0.27 (0.11–0.67)0.31 (0.13–0.77)<0.01
    Age and BMI adjusted1.00.70 (0.27–1.86)0.27 (0.11–0.67)0.29 (0.12–0.73)<0.01
    Multivariate* adjusted1.00.60 (0.21–1.71)0.27 (0.10–0.72)0.29 (0.10–0.82)0.03
BPH vs control subjects
    Age adjusted1.00.76 (0.34–1.70)0.60 (0.25–1.39)0.55 (0.23–1.28)0.65
    Age and BMI adjusted1.00.60 (0.26–1.41)0.58 (0.25–1.37)0.73 (0.33–1.62)0.62
    Multivariate* adjusted1.00.52 (0.20–1.34)0.49 (0.19–1.22)0.64 (0.27–1.50)0.47
  • * Multivariate model included age, BMI, smoking status, alcohol use, insulin level, and testosterone.